Business

July 7, 2014 11:03 AM

BioDelivery Sciences shares rise on positive drug trial results

BioDelivery Sciences International shares were up nearly 15 percent in early trading Monday after the Raleigh company announced positive Phase 3 clinical trial results for its experimental treatment for chronic pain.

Related content

Suggested for you

Comments

Videos

Today's Market

Nasdaq
Powered by Barchart

Editor's Choice Videos

Raleigh Top Jobs

View All Top Jobs